Medicare Enrolled

Dr. Sri Ranga Bonam, M.D.

Nephrology · Pomona, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1 MEDICAL PARK DRIVE, Pomona, NY 10970
8453625600
Registered in NPPES since 2006
NPI: 1659444800 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bonam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bonam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bonam

Dr. Sri Ranga Bonam is a nephrology specialist in Pomona, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bonam performed 1,876 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Bonam received a total of $8,596 from 44 pharmaceutical and/or device companies across 362 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bonam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 22% volume in NY $8,596 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,876
Medicare services
Top 22% in NY for nephrology
Not available
Unique patients (not deduplicated)
$138
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
749 $109 $225
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
204 $78 $150
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
198 $319 $700
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
186 $65 $150
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
180 $120 $300
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
107 $197 $576
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
104 $266 $700
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
102 $108 $240
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
22 $72 $155
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
13 $158 $420
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $78 $225
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,596
Total received (2018-2024)
Avg $1,228/year across 7 years
Top 13% in NY for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
362
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,084
2023
$2,061
2022
$2,021
2021
$413
2020
$185
2019
$1,075
2018
$757

Payments by company (2024)

Fresenius USA Marketing, Inc.
$304
Amgen Inc.
$292
AstraZeneca Pharmaceuticals LP
$217
Boehringer Ingelheim Pharmaceuticals, Inc.
$194
Vifor Pharma, Inc.
$149
Novartis Pharmaceuticals Corporation
$113
Travere Therapeutics, Inc.
$109
PFIZER INC.
$92
Otsuka America Pharmaceutical, Inc.
$85
Bayer Healthcare Pharmaceuticals Inc.
$80
Mallinckrodt Hospital Products Inc.
$69
Exact Sciences Corporation
$63
Ardelyx, Inc.
$60
ANI Pharmaceuticals, Inc.
$55
Aurinia Pharma U.S., Inc.
$51
OPKO Pharmaceuticals, LLC
$34
Novo Nordisk Inc
$33
Alnylam Pharmaceuticals Inc.
$26
Lilly USA, LLC
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
CALLIDITAS THERAPEUTICS US INC.
$15
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$880
Vifor Pharma, Inc.
$617
Amgen Inc.
$599
Fresenius USA Marketing, Inc.
$505
OPKO Pharmaceuticals, LLC
$496
Relypsa, Inc.
$402
ANI Pharmaceuticals, Inc.
$338
Otsuka America Pharmaceutical, Inc.
$317
Bayer HealthCare Pharmaceuticals Inc.
$309
Mallinckrodt Enterprises LLC
$300
GlaxoSmithKline, LLC.
$243
Travere Therapeutics, Inc.
$241
Boehringer Ingelheim Pharmaceuticals, Inc.
$236
Mallinckrodt Hospital Products Inc.
$232
Bayer Healthcare Pharmaceuticals Inc.
$224
Alexion Pharmaceuticals, Inc.
$192
Mallinckrodt LLC
$189
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$165
Novo Nordisk Inc
$158
Horizon Therapeutics plc
$152
Boston Scientific Corporation
$149
W. L. Gore & Associates, Inc.
$140
Novartis Pharmaceuticals Corporation
$137
Calliditas Therapeutics US Inc.
$133
Nevro Corp.
$127
Aurinia Pharma U.S., Inc.
$120
DePuy Synthes Sales Inc.
$117
PFIZER INC.
$110
Strongbridge US INC.
$89
AKEBIA THERAPEUTICS INC
$87
Exact Sciences Corporation
$86
Exeltis, USA Inc.
$84
CALLIDITAS THERAPEUTICS US INC.
$77
Ardelyx, Inc.
$60
Alnylam Pharmaceuticals Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$44
Horizon Pharma plc
$38
Ultragenyx Pharmaceutical Inc.
$31
ARBOR PHARMACEUTICALS, INC.
$25
Lilly USA, LLC
$24
Retrophin, Inc.
$24
GENZYME CORPORATION
$18
Otsuka Pharmaceutical Development & Commercialization, Inc.
$17
Keryx Biopharmaceuticals, Inc.
$12
Top 3 companies account for 24.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · Cologuard Collection Kit · Crysvita · Edarbi · FABRY-DISEASE · FARXIGA · Fabhalta · GATTEX · GIVLAARI · GORE VIABAHN Endoprosthesis · IBSRELA · JARDIANCE · JYNARQUE · KEVEYIS · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · ORTHOVISC · Ozempic · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Senza · TARPEYO · TAVNEOS · TEZSPIRE · Tavneos · ULTOMIRIS · Ultomiris · Velphoro · Veltassa · WATCHMAN Access System · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nephrology specialist in Pomona?
Compare nephrologists in the Pomona area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists in nearby ZIP areas
201
County median income
$110,631
Nearest hospital to ZIP centroid (approximate)
GOOD SAMARITAN HOSPITAL OF SUFFERN
4.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bonam is a clinical cardiology specialist, with above-average Medicare volume (top 22% in NY), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bonam experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Bonam performed 749 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bonam receive payments from pharmaceutical companies?
Yes. Dr. Bonam received a total of $8,596 from 44 companies across 362 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bonam's costs compare to other nephrologists in Pomona?
Dr. Bonam's average Medicare payment per service is $138. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bonam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →